by Brenda Baletti, Ph.D., Childrens Health Defense:
Advisers to the CDC on Wednesday also lowered the age recommendation for Pfizer and Merck’s pneumococcal conjugate vaccines, designed to protect against meningitis and pneumonia, from age 65 to age 50.
Advisers to the Centers for Disease Control and Prevention (CDC) on Wednesday recommended two COVID-19 boosters during the 2024-2025 season for people ages 65 and older and for younger people who are moderately or severely immunocompromised.
TRUTH LIVES on at https://sgtreport.tv/
The Advisory Committee on Immunization Practices (ACIP) also recommended that immunocompromised people ages 6 months and older take “additional doses” of the shot — three or more — based on shared clinical decision-making between doctor and patient.
The vote for all three new COVID-19 vaccine recommendations was unanimous.
The committee also voted 14-1 to recommend Pfizer and Merck’s pneumococcal conjugate vaccines — designed to protect against meningitis and pneumonia — for all adults who have never received the vaccine ages 50 and older, lowering the recommended age from 65.
The U.S. Food and Drug Administration in June approved Merck’s Capvaxive for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.
The vote expands the market for both companies, who will now be able to market their vaccines to millions more eligible adults, boosting their annual revenues by hundreds of millions of dollars, FiercePharma reported.
CDC Director Mandy Cohen endorsed the recommendations after the meeting, making them official CDC recommendations.
“CDC will continue to educate the public on how and when to get their updated vaccinations so they can risk less severe illness and do more of what they love,” Cohen said.
“ACIP loves advising that people receive the most vaccines possible,” internist Dr. Meryl Nass told The Defender.
She added:
“When ACIP talks about shared decision-making, what they mean is this: ‘We lack the data to recommend this vaccine for this group, so we could be criticized (or worse) for making an unscientific recommendation. But we really want you to have it.’
“So we think the patient and doctor (who is much less educated about the minutiae regarding the vaccine than the ACIP members are) should together decide whether the patient should get it. That way we protect ourselves while maximizing the number of jabs.’”
Nass said that if ACIP members were serious about shared clinical decision-making, “They would put all their thoughts down so clinicians could become educated and then jointly evaluate the risks and benefits with patients.”
The committee also voted unanimously to add high-dose and adjuvanted flu vaccines to the Vaccines for Children Program — which provides free vaccines to children whose families can’t afford them — for transplant recipients taking immunosuppressive medications.
ACIP is described as an independent, nonfederal expert body of professionals with clinical, scientific and public health expertise. The committee decides which vaccines should be recommended to the public, who should take them and how often.
In practice, most members have financial ties to vaccine makers that they don’t consider to be conflicts of interest. For example, in Wednesday’s meeting, paid Merck consultant and researcher Noel Brewer, Ph.D., declared “no conflict” before voting to recommend Merck’s vaccine.
Read More @ ChildrensHealthDefense.org
